August 25, 2019 – APBN New Site

Clinical – Stage Biotechnology Company Presents Murlentamab Phase II Study Results in Colorectal Cancer

August 25, 2019 . Bioboard

GamaMabs Pharma, developing optimized therapeutic antibodies targeting the Anti-Müllerian Hormone Receptor II (AMHRII) for the treatment of cancer, announces the oral presentation of clinical data...

Vitafoods Asia Conference to Present Top 5 APAC Nutraceutical Trends

August 25, 2019 . Inside Industry

The conference programme for Vitafoods Asia 2019 will cover 5 key themes shaping the Asia Pacific region and equip visitors with practical outcomes to help their businesses be more successful in the...